bpc-157 safety human use fda warning unapproved drug approved fda bpc-157 peptide not approved bpc-157 bpc-157 safety human clinical data

54/55 split billing for comanagement of surgical procedures (54: surgical care only, 55: postoperative management only)

According to an older 2013 review of research, they may have lipotropic effects in rodents: Very limited research exists on the efficacy, safety, and lipotropic properties of the ingredients used in these injections for weight loss

Giving them more frequently than the established schedule is a form of over-treatment that is not supported by evidence and can strain healthcare resources (nurses time, clinic space, and medication supplies)

Double check your math before injecting

Peptide Vials (GHK-Cu, 100 mg each): 5 days/week (1.0-2.0 mg/day): 8 weeks (~50 mg total): 1 vial 12 weeks (~90 mg total): 1 vial 16 weeks (~130 mg total): 2 vials 3 times/week (2 mg each): 8 weeks (~48 mg total): 1 vial 12 weeks (~72 mg total): 1 vial 16 weeks (~96 mg total): 1 vial Insulin Syringes (U-100, 29-31 gauge): 5 days/week: Per week: 5 syringes 8 weeks: 40 syringes 12 weeks: 60 syringes 16 weeks: 80 syringes 3 times/week: Per week: 3 syringes 8 weeks: 24 syringes 12 weeks: 36 syringes 16 weeks: 48 syringes Sterile or Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for the displayed calculation